If BETONMACE trial were to be done again today and all patients both placebo and treated groups would be on Jardiance, the new SGLT2 drug,...
Am i correct in assuming that even though the placebo rate would be much lower, our drug would work much better in synergy with Jardiance. Can i assume we would then pass the primary endpoint,...?
ThanksĀ